Recap: Corcept Therapeutics Q4 Earnings

Corcept Therapeutics CORT reported its Q4 earnings results on Thursday, February 15, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Corcept Therapeutics beat estimated earnings by 7.69%, reporting an EPS of $0.28 versus an estimate of $0.26.

Revenue was up $32.35 million from the same period last year.

Last quarter the company beat on EPS by $0.07 which was followed by a 9.97% drop in the share price the next day.

Here's a look at Corcept Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	0.21	0.15	0.19	0.22
EPS Actual	0.28	0.25	0.14	0.14
Revenue Estimate	119.34M	109.71M	104.87M	105.08M
Revenue Actual	123.60M	117.72M	105.65M	103.06M

To track all earnings releases for Corcept Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar